HHS Should Revisit HIPAA Privacy Regs, Consider Research Subjects’ Overall Welfare – Cmte.
This article was originally published in The Pink Sheet Daily
Executive Summary
The Secretary’s Advisory Committee on Human Research Protections says that the application of HIPAA has complicated research activities. SACHRP recommends that the exemption for disclosures by public health activities should be broadened.
You may also be interested in...
“Pharmaco-Metabonomics” Holds Promise for Personalized Drug Therapies, Researchers Say
The method uses a combination of advanced chemical analysis and mathematical modeling to predict drug response.
NCI-Funded Researchers Are Patenting At Surprisingly High Rate, Report Says
More than one in four National Cancer Institute-funded scientists start their own healthcare companies based on their own discoveries.
U.S. Overtakes Europe In New Drug Introductions, Study Finds
U.S. overtakes Europe in innovation between 1993 and 2003, introducing the most first-in-class, biotech and orphan products in the global market, according to a study authored by a Duke University economics professor
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: